(Q43224142)

English

Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan

scientific article published in December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

0 references

metabolic syndrome

1 reference

based on heuristic

inferred from title

author name string

Yin-Yi Chou

1

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Wayne H-H Sheu

2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Yih-Jing Tang

3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Yi-Ming Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Szu-Chia Liao

5

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Ya-Wen Chuang

6

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Chu-Sheng Lin

7

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Der-Yuan Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

publication date

1 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Archives of Gerontology and Geriatrics

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

49 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

S41-5

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The metabolic syndrome and cardiovascular disease: Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated C-reactive protein levels in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammation as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Metabolic Syndrome Is Associated With Circulating Adipokines in Older Adults Across a Wide Range of Adiposity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4943%2809%2970012-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0167-4943(09)70012-3

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43224142&oldid=1984160994"